Table 8.
Genes | Planned contrast1) | ||
---|---|---|---|
| |||
CON vs G10 | CON vs TM | CON vs G10+TM | |
SOD | NS | NS | NS |
CAT | NS | NS | 0.046 |
GPx1 | NS | 0.092 | 0.006 |
NOX1 | 0.001 | 0.019 | 0.007 |
NOX4 | 0.077 | NS | NS |
ACC | NS | NS | NS |
FAS | 0.065 | NS | NS |
NRF2 | 0.039 | NS | NS |
EXFABP | NS | NS | 0.087 |
PPAR-γ | NS | NS | NS |
The treatments are described as follows: CON, control eggs without in ovo injection and incubated at standard temperature; G10, eggs injected at 17.5 days of incubation with 0.6 mL of 10% γ-aminobutyric acid dissolved in distilled water; TM, thermally manipulated eggs exposed to 39.6°C for 6 h daily from embryonic day 10 to 18; G10+TM, eggs that received both previous treatments during incubation. Chicks obtained were grown for 28 days.
SOD, superoxide dismutase; NS, not significant; CAT, catalase; GPx1, glutathione peroxidase 1; NOX1, nicotinamide adenine dinucleotide phosphate oxidase 1; NOX4, nicotinamide adenine dinucleotide phosphate oxidase 4; ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; NRF2, nuclear factor erythroid 2-related factor 2; EXFABP, extracellular fatty acid-binding protein; PPAR-γ, peroxisome proliferator-activated receptor-gamma.